Leases - Narrative (Details) ft² in Thousands, $ in Thousands, squareFeet in Millions		1 Months Ended	3 Months Ended	12 Months Ended
	Oct. 26, 2023 USD ($) lease	Jul. 31, 2024 ft² squareFeet	Mar. 31, 2023 USD ($) lease	Dec. 31, 2025 USD ($)	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($) lease	Jun. 30, 2024
Lessor, Lease, Description [Line Items]
Corporate assets				$ 45,000	$ 38,000
Straight line rent				39,190	41,276	$ 14,387
Litigation settlement, amount awarded from other party						4,000
Cash paid for amounts included in the measurement of lease liability for operating leases				$ 20,426	21,277	$ 21,488
Operating lease, area of square feet renewed | squareFeet		2
Operating lease, annual lease escalations (in percent)		0.030					0.025
Area of square feet with early termination right | ft²		200
Sorrento Therapeutics, Inc.
Lessor, Lease, Description [Line Items]
Straight line rent			$ 9,000
Number of leases | lease			4			4
Number of leases approved | lease						3
Graphite Bio, Inc
Lessor, Lease, Description [Line Items]
Number of leases | lease	1
Cash paid for amounts included in the measurement of lease liability for operating leases	$ 37,000
Termination fees	21,000
Prepayment of rent	16,000
Rent adjustments	$ 37,000
Common Spirit | Outpatient Medical
Lessor, Lease, Description [Line Items]
Segment revenues (in percent)				6.00%
Common Spirit | Outpatient Medical | Largest Tenant | Percentage of Total Company Revenues | Customer Concentration Risk
Lessor, Lease, Description [Line Items]
Concentration risk (as a percent)				3.00%
General and Administrative Expense
Lessor, Lease, Description [Line Items]
Depreciation expense related to corporate assets				$ 3,000	2,000	$ 3,000
Other Assets
Lessor, Lease, Description [Line Items]
Accumulated depreciation related to corporate assets				$ 10,000	$ 8,000